ITVISMA
onasemnogene abeparvovec-brve
Listed by Novartis Innovative Technologies Inc.
- Strength
- 40000000000000 [arb'U]/mL
- Form
- Injection, Suspension
- Route
- Intrathecal
What it contains
- Onasemnogene Abeparvovec 40000000000000 [arb'U]/mL
FDA record
| Dosage form | Injection, Suspension |
|---|---|
| Route | Intrathecal |
| Approval route | BLA — biologic licence |
| NDC code | 71894-200 |
| FDA application | BLA125856 |
| RxNorm concept | 2727307 |
| Package sizes listed | 1 |
| Marketed since | November 2025 |
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.